Professor of Otolaryngology, University MD School of Medicine
Otolaryngology (ENT)
Dr. Scott E. Strome, MD
|
|
Give Review
Scott E. Strome, MD works in the field of Otolaryngology (ENT). He graduated from Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He over the years received 8 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Top Doctors:Baltimore Area", "Top Doctors:Washington-Baltimore", "Fellow (FAAO-HNS)", "Whos Who in Medicine and Healthcare", "Super Doctor" and "Fellow (FACS)". Scott Strome is also published. He has 67 publications published. The lastest publication: "Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease.
- Impact of Detachment Methods on M2 Macrophage Phenotype and Function.
- Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional.
- Fc fusion as a platform technology: potential for modulating immunogenicity.
- A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of ...
- Oropharyngeal Cancer (OPC) drives racial outcome disparities in squamous cell carcinoma of the head and neck (HNSCC): Ten year experience at the university of maryland...
- Immature Teratoma of the Maxillary Sinus: A Rare Pediatric Tumor.
- The anti-lymphoma activities of anti-CD137 monoclonal antibodies are enhanced in FcγRIII(-/-) mice.
- The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the Head and neck.
- Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autolo...
- Response to "What are the best management strategies for radiation- induced xerostomia?"
- What are the best management strategies for radiation-induced xerostomia?
- Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon...
- Surgical management of cranioFacial neurofibromatosis type 1 associated tumors.
- Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma.
- A high throughput method for enrichment of natural killer cells and lymphocytes and assessment of in vitro cytotoxicity.
- CD40 Mediates Downregulation of CD32B on Specific Memory B Cell Populations in Rheumatoid Arthritis.
- What is the value of hyperbaric oxygen therapy in management of osteoradionecrosis of the Head and neck?
- Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell Cancer of the head and neck treated with definit...
- Herpesvirus entry mediator regulates hypoxia-inducible factor-1? and erythropoiesis in mice.
- Bone marrow vaccination: A novel approach to enhance antigen specific antitumor immunity.
- Cell Type-Specific Transcriptome Analysis Reveals a Major Role for Zeb1 and miR-200b in Mouse Inner Ear Morphogenesis.
- A noncoding point mutation of Zeb1 causes multiple developmental malformations and obesity in Twirler mice.
- Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory.
- Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for Cancer immunotherapy.
- Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010.
- Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
- CD44 is a marker for the outer pillar cells in the early postnatal mouse inner ear.
- B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.
- CD137 promotes proliferation and survival of human B cells.
- Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas.
- Racial survival disparity in head and neck Cancer results from low prevalence of human papillomavirus infection in black oropharyngeal Cancer patients.
- Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodies.
- Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.
- Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion.
- A mechanistic perspective of monoclonal antibodies in Cancer therapy beyond target-related effects.
- Oral lactoferrin results in T cell-dependent tumor inhibition of Head and neck squamous cell carcinoma in vivo.
- Informed consent in advanced laryngeal Cancer.
- CD8+ memory T lymphocytes from Bone marrow--immune function and therapeutic potential.
- Human Bone marrow: a reservoir for "enhanced effector memory" CD8+ T cells with potent recall function.
- Organ preservation for advanced Laryngeal carcinoma.
- Effacing of the T cell compartment by cardiac transplantation in infancy.
- Development and immunophenotyping of squamous cell carcinoma xenografts: tools for translational immunology.
- A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patien...
- Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
- Coronoid-temporalis pedicled rotation flap for orbital floor reconstruction of the total maxillectomy defect.
- Costimulation-based immunotherapy for head and neck Cancer.
- Interleukin-13 receptor alpha2 chain in human head and neck Cancer serves as a unique diagnostic marker.
- Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family.
- B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
- Identification of NY-ESO-1, MAGE-1, and MAGE-3 in Head and neck squamous cell carcinoma.
- Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
- Her-2/neu expression in ovarian Cancer: pre- and postexposure to platinum chemotherapy.
- Swallow function in patients before and after intra-arterial chemoradiation.
- Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis.
- Merkel cell carcinoma of the Head and neck: a retrospective case series.
- Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity.
- Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
- Two cases of coincident carcinomas of the Head and neck and the uterine cervix.
- Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations.
- Glomus jugulare tumor: tumor control and complications after stereotactic radiosurgery.
- Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
- Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.
- Reassessment of CD62L as a marker of pre-effector T cells in the tumor draining lymph nodes of head and neck Cancer patients.
- Advanced larynx Cancer.
- Interleukin 4 receptor-directed cytotoxin therapy for human Head and neck squamous cell carcinoma in animal models.
Schools
Harvard Medical School
Procedures Preformed
- Diagnostic Nasal and-or Sinus Endoscopy
- Ethmoidectomy (Sinus Surgery)
- Excision of Parotid, Sublingual, or Submandibular Gland
- Excision of Tracheal Tumor or Stenosis
- View All
Conditions Treated
- Acoustic Neuroma
- Acute Laryngitis
- Acute Tonsillitis
- Allergic Rhinitis
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
- Fellow (FAAO-HNS)
- Whos Who in Medicine and Healthcare
- Super Doctor
- Fellow (FACS)
Education
-
University of Michigan Hospitals and Health Centers -
Harvard Medical School
Hospital
-
University of Maryland Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457368771 |
| Last Name Of The Provider | STROME |
| First Name Of The Provider | SCOTT |
| View All |
Similar Doctors
|
|
Dr. Charles Limb, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kofi D. Boahene, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew Lane, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Yuri Agrawal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carole Fakhry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anwar M. Mumtaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacey Ishman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kiran B. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Wolf, MD |
|
|
Dr. Ian-James K. Malm, MD |
|
|
Dr. David J. Mener, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Robert J. Briggs, MB |